BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25534383)

  • 1. Clearer picture of PMS2-associated lynch syndrome is emerging.
    Daniels MS; Lu KH
    J Clin Oncol; 2015 Feb; 33(4):299-300. PubMed ID: 25534383
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishing cancer risks associated with PMS2 germline mutations in Lynch syndrome.
    Caron NS
    Clin Genet; 2015 Jun; 87(6):533-4. PubMed ID: 25761717
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
    Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
    [No Abstract]   [Full Text] [Related]  

  • 4. Germline PMS2 mutations: one hit or two?
    Gryfe R; Gallinger S
    Gastroenterology; 2005 May; 128(5):1506-9. PubMed ID: 15887130
    [No Abstract]   [Full Text] [Related]  

  • 5. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
    ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
    J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
    Ponti G; Ruini C; Tomasi A
    Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
    [No Abstract]   [Full Text] [Related]  

  • 7. PMS2 mutations in HNPCC.
    Hayward BE; De Vos M; Sheridan E; Bonthron DT
    Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
    Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
    Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of Lynch syndrome.
    Boland CR
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical problem-solving. Spot diagnosis.
    Stark Z; Campbell LJ; Mitchell C; James PA; Heath JA; Boussioutas A; Lynch C; Trainer AH
    N Engl J Med; 2014 Jun; 370(23):2229-36. PubMed ID: 24897087
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipating phenotypic differences from genetic mutations.
    You YN
    Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706
    [No Abstract]   [Full Text] [Related]  

  • 15. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
    Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
    J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
    de Vos M; Hayward B; Bonthron DT; Sheridan E
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
    Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
    Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening to detect Lynch syndrome and prevent hereditary cancers in relatives.
    Haddow JE; Palomaki GE
    J Med Screen; 2011; 18(4):167-8. PubMed ID: 22184732
    [No Abstract]   [Full Text] [Related]  

  • 20. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome.
    van der Klift HM; Tops CM; Hes FJ; Devilee P; Wijnen JT
    Hum Mutat; 2012 Jul; 33(7):1051-5. PubMed ID: 22461402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.